This paper summed up the characteristics of native arteriovenous fistulas (AVFs) in maintenance
hemodialysis patients with type 2 diabetic nephropathy (DN) in Chinese hemodialysis centers. A survey was
conducted on AVF in maintenance hemodialysis patients with type 2 DN. A total of 224 cases of maintenance
hemodialysis patients were included in this study, among which, 65 cases in DN group, 33 cases in diabetes
mellitus (DM) group and 126 cases in non-diabetic control (C) group. Hemoglobin, albumin, blood urea nitrogen,
parathyroid hormone and calcium-phosphate product of the three groups of patients were not significantly different.
Glycated hemoglobin A1c of DN group and DM group was not significant different. AVF life of (28.7 ± 10.0)
months in DN group was significantly shorter than that of (36.5 ± 19.4) months in C group (statistic probability
P <0.01), and AVF life of (32.5 ± 10.1) months in DM group (P <0.05) was also shorter than that in C group,
while there was no significant difference in AVF life between DN group and DM group. Proportion of upper arm
fistula in DN patients (11/65) was significantly higher than that in C group (6/123, P < 0.01). Life of AVF in
patients with DN was relatively short, with more times of angioplasty and greater possibility of selecting upper
arm internal fistula.
WANG Feng1 (王 锋), ZHOU Yang2 (周 阳), LI Jun-hui1 (李军辉), GUI Ding-kun1 (桂定坤),LU Shi3 (陆 石), YAO Yuan-zhang4 (姚源璋), LIU Li-mei5 (刘丽梅), SHENG Xiao-hua1 (盛晓华),PENG Wen6* (彭 文), WANG Nian-song1* (汪年松)
. Survey on Arteriovenous Fistula in Maintenance Hemodialysis Patients with Type 2 Diabetic Nephropathy[J]. Journal of Shanghai Jiaotong University(Science), 2012
, 17(6)
: 761
-764
.
DOI: 10.1007/s12204-012-1360-3
[1] Nakai S, Suzuki K, Masakane I, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008) [J]. Therapeutic Apheresis and Dialysis, 2010, 14(6): 505-540.
[2] Ritz E, Zeng X X, Rychlk I. Clinical manifestation and natural history of diabetic nephropathy [J]. Contributions to Nephrology, 2011, 170: 19-27.
[3] Yu Q, Yu H, Huang J B, et al. Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: A single-center study [J]. Journal of Nephrology, 2011, 24(5): 597-603.
[4] Wang F, Xing T, Wang N S, et al. A clinical study of pregnancy associated renal insufficiency [J]. Kidney and Blood Pressure Research, 2011, 34(1): 34-40.
[5] Wang F, Cheng D S, Wang N S, et al. Continuous glucose monitoring in the patients with diabetic nephropathy [J]. Journal of Shanghai Jiaotong University: Science, 2011, 16(4): 508-512.
[6] Konner K. Primary vascular access in diabetic patients: An audit [J]. Nephrology Dialysis Transplantation, 2000, 15(9): 1317-1325.
[7] Wang F, Xing T, Wang N S, et al. Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy [J]. Cytokine, 2012, 57(1): 127-129.
[8] Wang F, Bai M, Xing T, et al. Phimosis: A cause of chronic kidney diasease [J]. African Journal of Microbiology Research, 2012, 6(3): 701-703.
[9] Woo K, Farber A, Doros G, et al. Evaluation of the efficacy of the transposed upper arm arteriovenous fistula: A single institutional review of 190 basilic and cephalic vein transposition procedures [J]. Journal of Vascular Surgery, 2007, 46(1): 94-99.
[10] Hammes M S, Boghosian M E, Cassel K W, et al. Characteristic differences in cephalic arch geometry for diabetic and non-diabetic ESRD patients [J]. Nephrology Dialysis Transplantation, 2009, 24(7): 2190-2194.
[11] Racki S, Zaputovic L, Vujicic B, et al. Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: A single-centre experience [J]. Diabetes Research and Clinical Practice, 2007, 75(2): 169-175.
[12] Mauri J M, Vela E, Cleries M. Development of a predictive model for early death in diabetic patients entering hemodialysis: A population-based study [J]. Acta Diabetologica, 2008, 45(4): 203-209.
[13] Satirapoj B. Review on pathophysiology and treatment of diabetic kidney disease [J]. Journal of the Medical Association of Thailand, 2010, 93(sup6): 228-241.
[14] Passadakis P S, Oreopoulos D G. Diabetic patients on peritoneal dialysis [J]. Seminars in Dialysis, 2010, 23(2): 191-197.
[15] Segal J H, Kayler L K, Henke P, et al. Vascular access outcomes using the transposed basilic vein arteriovenous fistula [J]. American Journal of Kidney Disease, 2003, 42(1): 151-157.
[16] Moon J Y, Jeong K H, Paik S S, et al. Arteriovenous fistula patency associated with angiotensinconverting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade [J]. Nephron Clinical Practice, 2009, 111(2): 110-116.
